Endovascular Devices Market valued at US$ 5.4 bn in 2021 and is anticipated to grow at a CAGR of 5% By 2026

1
Endovascular Devices Market Top Companies
Analysis To Grow Your Business till 2026
2
Endovascular surgery is an advanced procedure
that is performed using minimally invasive
catheter techniques on the arteries or veins.
Procedures include aneurysm repair,
cardiovascular disorders, peripheral vascular
diseases, renal vascular diseases, deep vein
thrombosis (DVT), varicose vein repair, stroke,
among others. A wide variety of guidewires,
catheters, crossing devices, balloons, stents,
atherectomy devices, drug-coated devices, and
other devices are used for endovascular
treatment. The Global Endovascular Devices
Market valued at US 5.4 bn (2021) is projected
to witness a growth rate of 5 in the next five
years. Rising preference for endovascular
aneurysm repair (EVAR) procedures, technological
advancements in endovascular devices, the
increasing geriatric population corresponding
rise in the prevalence of cardiovascular
diseases, lifestyle factors (diet, exercise),
ease availability of endovascular procedures,
and favourable reimbursements for endovascular
procedures are some of the key factors driving
the global Endovascular devices
market. Cumulative Preference for Endovascular
Aneurysm Repair (EVAR) Procedure Opens Growth
Opportunities for Endovascular Devices Market An
aortic aneurysm is a bulge that occurs in the
wall of the aorta that carries blood from the
heart to the body. It increases the risk of
developing a tear in the inner layer of the wall
of the aorta. An aortic aneurysm can be abdominal
or thoracic. An abdominal aortic aneurysm (AAA)
occurs when a portion of the abdominal aorta
bulges into an aneurysm because of a weakening of
the vessel wall. AAA may result in
life-threatening internal bleeding upon rupture
and hence patients diagnosed with AAA are treated
with open surgical repair or mostly via less
invasive endovascular aneurysm repair (EVAR).
During the EVAR procedure, a stent graft is
inserted into the aorta which protects the aorta
from tearing. 
3

• The EVAR is widely accepted as a standard of care
  for aortic aneurysms supported by vascular
  surgeons due to the following benefits
• Shorter stay in the hospital.
• Relatively less blood loss
• Faster return to routine activities
• Shorter procedure time as compared to open
  surgery, among others
• Citing the lucrative prospects of EVAR
  technology, companies are launching innovative
  products in new markets.
• For instance,
• In May 2021, Endologix launched Alto Abdominal
  Stent Graft System in Canada and Argentina. The
  launch boots the companys global reach with the
  latest endovascular aneurysm repair (EVAR)
  technology
• Endovascular aneurysm repair (EVAR) has emerged
  as a safe, and effective method of treating
  abdominal aortic aneurysms as it lowers the risk
  of life-threatening tears ruptures.
  Technological advancements in EVAR have not only
  allowed vascular surgeons to achieve therapeutic
  aims but also reduced procedural risks and
  patient discomfort." - Director, Leading
  Endovascular Device Manufacturer, United States
• Explore Premium Report on Endovascular Devices
  Market _at_ https//meditechinsights.com/endovascular
  -devices-market/

4

• Technological Advancements Drive the Global
  Endovascular Devices Market
• The endovascular devices market is a
  technology-driven market and is marked by product
  enhancements/innovations.
• For instance,
• In June 2022, Medtronic India launched a
  fourth-generation flow diverter, Pipeline Vantage
  with Shield Technology for endovascular treatment
  of brain aneurysms
• Organic and Inorganic Advance Strategies Adopted
  by Players to Establish Their Position in
  Endovascular Devices Market
• The endovascular devices market is marked by the
  presence of both established and new players.
  Players operating in the market adopt both
  organic and inorganic growth strategies such as
  acquisitions, and new product launches to garner
  market share.
• For instance,
• In March 2022, Cook Medical received FDA
  Breakthrough Device Designation for Zenith
  Thoraco Endovascular System. The Thoraco is
  built on the strength of the proven Zenith
  platform and represents a next-generation
  endovascular graft for the treatment of
  thoracoabdominal aortic aneurysms. The system is
  indicated for the endovascular treatment of
  patients with thoracoabdominal aortic aneurysm

5
The endovascular devices market is expected to
continue to grow in the coming years due to
growing cases of peripheral, aortic, venous
diseases, an increase in the smoking population,
growth opportunities in the APAC region,
technological advancements in endovascular
devices, and favorable reimbursement in key
markets. Competitive Landscape Analysis of
Endovascular Devices Market The global
endovascular devices market is marked by the
presence of players such as Cordis, Medtronic,
Boston Scientific, Cook Medical, Abbott, Gore
Medical, Cardiovascular Systems, Inc. (CSI),
Terumo, among others. For More Detailed
Insights, Contact Us _at_ https//meditechinsights.co
m/contact-us/ About Medi-Tech Insights Medi-Tech
Insights is a healthcare-focused business
research insights firm. Our clients include
Fortune 500 companies, blue-chip investors
hyper-growth start-ups. We have completed 100
projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices Pharma
Services. Contact Ruta Halde Associate,
Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com